On that note, we have previously examined the response of seven human melanoma cell lines and five melanoma patient-derived xenografts to treatment with a CDK4/6 inhibitor alone or in combination with an MDM2 inhibitor (17). This evidence concerns the gene MDM2 and melanoma.